Every SEC Form 3/4/5 on record for this filer (CIK 1985496) — 1 issuer, 36 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| GYRE | GYRE THERAPEUTICS, INC. | Chief Operating Officer | 2023-11-01 → 2026-06-22 | 13 | −$869,947 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| GYRE | 2026-06-18 | Sell | 3,000 | $6.35 | $19,050 | 700,000 |
| GYRE | 2026-06-11 | Sell | 2,800 | $6.17 | $17,276 | 700,000 |
| GYRE | 2026-06-10 | Sell | 6,418 | $6.21 | $39,856 | 700,000 |
| GYRE | 2026-06-10 | Sell | 5,000 | $6.24 | $31,200 | 700,000 |
| GYRE | 2026-06-09 | Sell | 14,500 | $6.14 | $89,030 | 700,000 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.